ArticleCells2026
Protein Kinase C Promotes Notch1 Cleavage Through Both Ligand-Dependent and Hyaluronic Acid-ADAM10-Dependent Mechanisms.
Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Notch1 signaling is essential for endothelial cell fate determination and vascular development. While PKC has been implicated as an upstream activator of Notch1 signaling, the molecular mechanisms by which PKC promotes Notch1 proteolytic cleavage remain poorly defined. Here, using murine endothelial MS1 cells and mouse aortic endothelial cells (MAECs), we identify two cooperative pathways through which PKC drives generation of the Notch1 intracellular domain (NICD). First, PKC activation increases mRNA and protein levels of the Notch1 ligands Jag1 and Dll4. A NICD-Dll4 positive feedback loop further amplifies Notch signaling. Second, PKC upregulates hyaluronic acid synthase 2 (HAS2) mRNA and protein expression, promoting hyaluronan (HA) synthesis. Various genetic (HAS2 knockdown, CD44 knockdown, Hyal2 overexpression) and pharmacological (4-methylumbelliferone, 4-MU) treatments confirmed that HA is required for PKC to activate Notch1. Inhibition of HA production or signaling is associated with downregulation of ADAM10 on the cell surface. Direct phosphorylation of Notch1 at S1791 is dispensable for this effect. Together, these findings reveal a dual pathway model in which PKC coordinates ligand upregulation and HA signaling to promote Notch1 cleavage, identifying the extracellular matrix as a previously unrecognized regulator of Notch1 signal strength in endothelial cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.